ZNF503 and dry age related macular degeneration: Furthermore, nuclear factor κB was identified as a potential transcription factor for ZNF503-AS1. Taken together, this study identified the ZXNF503-AS1 lncRNA as a potential biomarker and therapeutic target in dry AMD, and its involvement in the dry AMD pathogenesis may include the dedifferentiation of RPE cells.